Paragon Therapeutics
PrivateCompany Overview
Paragon Therapeutics is a biotechnology company that leverages cutting-edge science and technology to identify and develop best-in-class biologics for a range of human diseases with high unmet needs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paragon Therapeutics Comparables
Compare Paragon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IFM Therapeutics | 81% | |
| Cumulus Oncology | 77% | |
| Retromer Therapeutics | 76% |
Paragon Therapeutics Funding Rounds
Historical fundraising activity
Paragon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Paragon Therapeutics's valuation, stock price, and market status.
Is Paragon Therapeutics a public or private company?
Paragon Therapeutics is a private company.
What is the current stock price of Paragon Therapeutics?
Paragon Therapeutics is a private company with no public stock price. Caplight tracks Paragon Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Paragon Therapeutics worth (valuation)?
Valuation information for Paragon Therapeutics is not publicly available.
Can I buy Paragon Therapeutics stock?
Paragon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Paragon Therapeutics's last funding round?
Funding round information for Paragon Therapeutics is not publicly available.
Who are the main investors in Paragon Therapeutics?
Investor information for Paragon Therapeutics is not publicly disclosed.
Will Paragon Therapeutics IPO soon?
No public IPO plans have been announced for Paragon Therapeutics.
How can I track Paragon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paragon Therapeutics's secondary market activity and sign up for updates.